Enveric Biosciences Financial Overview
Enveric Biosciences's market cap is currently $3.13M. The company's EPS TTM is $-11.64; its P/E ratio is -0.05; Enveric Biosciences is scheduled to report earnings on August 14, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
